Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Abstract Brain glioma treatment with checkpoint inhibitor antibodies to cytotoxic T-lymphocyte-associated antigen 4 (a-CTLA-4) and programmed cell death-1 (a-PD-1) was largely unsuccessful due to their inability to cross blood–brain barrier (BBB). Here we describe targeted nanoscale immunoconjugates...

Full description

Bibliographic Details
Main Authors:	Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova, Antonella Chiechi, Alan J. Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G. Tourtellotte, Liron L. Israel, Oliver Braubach, Vladimir A. Ljubimov, Leila A. Mashouf, Arshia Ramesh, Zachary B. Grodzinski, Manuel L. Penichet, Keith L. Black, Eggehard Holler, Tao Sun, Hui Ding, Alexander V. Ljubimov, Julia Y. Ljubimova
Format:	Article
Language:	English
Published:	Nature Portfolio 2019-08-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-019-11719-3

Similar Items

Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
by: Anna Galstyan, et al.
Published: (2020-01-01)

Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
by: Rameshwar Patil, et al.
Published: (2021-10-01)

Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
by: Julia Y. Ljubimova, et al.
Published: (2021-11-01)

Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study
by: Liron L. Israel, et al.
Published: (2023-10-01)

Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
by: Patil R, et al.
Published: (2020-05-01)

Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
by: Satoshi Inoue, et al.
Published: (2012-01-01)

Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.
by: Jinwei Hu, et al.
Published: (2010-04-01)

Targeted Therapy With Immunoconjugates for Multiple Myeloma
by: Wassilis S. C. Bruins, et al.
Published: (2020-06-01)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

Ordered and Kinetically Discrete Sequential Protein Release from Biodegradable Thin Films
by: Jamieson, Kelsey S., et al.
Published: (2016)

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.
by: King, D, et al.
Published: (1995)

Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells
by: Soni Khandelwal, et al.
Published: (2018-10-01)

Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects
by: Huang, Huang-Chiao, et al.
Published: (2022)

Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas.
by: Michael A Winkler, et al.
Published: (2014-01-01)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
by: Cornelissen, B, et al.
Published: (2011)

Effectiveness of Polyclonal Antibody Immunoconjugate Treatment with Propamidine Isethionate for Amoebic Keratitis in Golden Hamsters
by: Manuel Enrique Ávila-Blanco, et al.
Published: (2023-01-01)

Evaluation of immunoconjugates of non-radioactive lutetium- and yttrium-rituximab – a vibrational spectroscopy study
by: Darinka Gjorgieva Ackova, et al.
Published: (2015-11-01)

Multilayer Films Assembled from Naturally-Derived Materials for Controlled Protein Release
by: Veselinovic, Jovana, et al.
Published: (2016)

Cell-free circulating tumor DNA in cancer
by: Zhen Qin, et al.
Published: (2016-04-01)

Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
by: Spring, Bryan Q., et al.
Published: (2014)

Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin
by: Candy S. Hwang, et al.
Published: (2018-09-01)

EP-2324: Non-invasive PET imaging of radiosensitive tumour regions using γH2AX-targeted immunoconjugate
by: Yaromina, A, et al.
Published: (2018)

Fc epsilon RI immunoconjugate inhibits IgE-mediated passive cutaneous anaphylaxis (PCA) in the rat
by: Holland, K, et al.
Published: (1999)

Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC
by: Zhang Tao, et al.
Published: (2022-12-01)

Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate
by: Emna Hannachi, et al.
Published: (2019-09-01)

Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.
by: Christian Wulbrand, et al.
Published: (2013-01-01)

111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
by: Cornelissen, B, et al.
Published: (2009)

Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8+ T Cells in Exacerbation of Eye Disease
by: Ujjaldeep Jaggi, et al.
Published: (2018-12-01)

Modifications of Microvascular EC Surface Modulate Phototoxicity of a Porphycene anti-ICAM-1 Immunoconjugate; Therapeutic Implications
by: Duran-Frigola, Miquel, et al.
Published: (2015)

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
by: Andrea Zanello, et al.
Published: (2022-08-01)

Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis
by: Benjamin Korman, et al.
Published: (2018-07-01)

Measurement of weak magnetic field of corrosion current of isolated corrosion center
by: I. V. Bardin, et al.
Published: (2015-01-01)

PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
by: Knight, J, et al.
Published: (2015)

PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
by: Knight, J, et al.
Published: (2015)

Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the <sup>64</sup>Cu-Labelling of Immunoconjugates
by: Aurélie Maisonial-Besset, et al.
Published: (2022-12-01)

Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates.
by: Ryan B Craig, et al.
Published: (2012-01-01)

FHR4‐based immunoconjugates direct complement‐dependent cytotoxicity and phagocytosis towards HER2‐positive cancer cells
by: Carole Seguin‐Devaux, et al.
Published: (2019-12-01)

Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases
by: Zhiwei Hu
Published: (2018-01-01)

Differentially expressed wound healing-related microRNAs in the human diabetic cornea.
by: Vincent A Funari, et al.
Published: (2013-01-01)

A Nanomedicine Approach to Manage Cancer – Imaging Pancreatic Cancer Using Targeted Iron Oxide Nanoparticles
by: Liron L. Israel
Published: (2018-04-01)